Cargando…
The future of therapy for alcoholic hepatitis – Beyond corticosteroids
Autores principales: | Vergis, Nikhil, Atkinson, Stephen R., Thursz, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420340/ https://www.ncbi.nlm.nih.gov/pubmed/30791978 http://dx.doi.org/10.1016/j.jhep.2019.01.016 |
Ejemplares similares
-
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
por: Vergis, Nikhil, et al.
Publicado: (2017) -
Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention
por: Skinner, Charlotte, et al.
Publicado: (2020) -
Psychosocial and Pharmacological Therapies to Reduce Alcohol Consumption in Severe Alcohol-Related Hepatitis Patients: A Case Report
por: Awan, Humza, et al.
Publicado: (2023) -
Systemic Activin Is Elevated in Patients With Severe Alcoholic Hepatitis
por: STAUDACHER, J. J., et al.
Publicado: (2022) -
IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis
por: Vergis, N., et al.
Publicado: (2021)